(Q71520597)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

OK-432 therapy for lymphangioma in children: why and how does it work? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

S Ogita

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

T Tsuto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

K Nakamura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

E Deguchi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

K Tokiwa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

N Iwai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

English

0 references

publication date

1 April 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pediatric Surgery

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

477-480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

OK-432 therapy for unresectable lymphangiomas in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

OK-432 therapy in 64 patients with lymphangioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

Intrapleural administration of OK432 in cancer patients: Activation of nk cells and reduction of suppressor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

Neutrophil-mediated tumor cell destruction in cancer ascites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2896%2990478-9

10.1016/S0022-3468(96)90478-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8801295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference